Experimental vaccine fails to protect babies against TB

02/4/2013 | Medical News Today

The MVA85A vaccine has been developed to boost the immune responses of the Bacille Calmette-Guérin vaccine against tuberculosis, but a trial in South Africa found that the experimental vaccine was not as effective in babies as it has been shown to be in adults. The vaccine's efficacy rate of 17.3% was not statistically significant, researchers reported in The Lancet.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC